Riyadh - Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) inked a memorandum of understanding (MoU) with the General Administration of Pharmaceutical Care at the Ministry of Health Saudi Arabia, according to a press release.
The partnership aims to support the development of healthcare and pharmaceutical professionals through training programs and educational initiatives, achieving the objectives of Saudi Vision 2030.
This aligns with the group’s strategy to advance the sector by investing in healthcare and pharmaceutical talent development, expanding community awareness programs, and widening collaboration with government health entities.
Both parties will collaborate on implementing developmental programs across administrative, technical, and specialized fields, in addition to designing and developing curriculums in line with the professional global standards and organizing workshops, seminars, and forums related to pharmaceutical training and development.
Jamjoom Pharma operates in more than 37 countries across the Middle East and Africa, with core operations in Saudi Arabia, the UAE, Iraq, the Levant, Egypt, and North Africa. It recorded 7.11% higher net profits at SAR 168.21 million in the first quarter (Q1) of 2026, compared with SAR 157.03 million a year earlier.
